Which description best summarizes 21 CFR Part 211 (subparts A-K)?

Which description best summarizes 21 CFR Part 211 (subparts A-K)?

• A. GMP requirements for finished pharmaceuticals
• B. Labeling standards
• C. Import/export controls
• D. Clinical trial reporting guidelines

Answer: (C)

21 CFR Part 211 establishes current good manufacturing practice requirements for finished pharmaceutical products. It lays out a comprehensive quality system across subparts A through K, covering responsibilities, facilities and equipment, personnel, production and process controls, packaging and labeling controls, hold and distribution, laboratory controls, records and reports, and related quality activities. The aim is to prevent contamination, mix-ups, and deviations so that drug products consistently meet quality and safety standards. This regulation is broader than just labeling standards, and it does not govern import/export controls or clinical trial reporting guidelines, which are addressed in other parts of the CFR. So the description that best fits is GMP requirements for finished pharmaceuticals.

21 CFR Part 211 establishes current good manufacturing practice requirements for finished pharmaceutical products. It lays out a comprehensive quality system across subparts A through K, covering responsibilities, facilities and equipment, personnel, production and process controls, packaging and labeling controls, hold and distribution, laboratory controls, records and reports, and related quality activities. The aim is to prevent contamination, mix-ups, and deviations so that drug products consistently meet quality and safety standards. This regulation is broader than just labeling standards, and it does not govern import/export controls or clinical trial reporting guidelines, which are addressed in other parts of the CFR. So the description that best fits is GMP requirements for finished pharmaceuticals.